Rep Amy J. Laufer (HD-055)
Virginia Housesince 10 months
SEE LATEST
SPONSORED LEGISLATION
HB35 - Firearm safety device tax credit; expands definition of device.
Nadarius E. Clark, Alfonso H. Lopez, Jackie H. Glass
Last updated 8 months ago
22 Co-Sponsors
Firearm safety device tax credit; definition of firearm safety device. Expands the definition of "firearm safety device" as it relates to the firearm safety device tax credit to include any device that, when installed on a firearm, is designed to prevent the firearm from being operated without first deactivating the device. The provisions of the bill are effective for taxable years beginning on and after January 1, 2024.
STATUS
Passed
HB819 - Health insurance; coverage for contraceptive drugs and devices.
Candi Mundon King, Dan I. Helmer, Kannan Srinivasan
Last updated 6 months ago
20 Co-Sponsors
Health insurance; coverage for contraceptive drugs and devices. Requires health insurance carriers to provide coverage, under any health insurance contract, policy, or plan that includes coverage for prescription drugs on an outpatient basis, for contraceptive drugs and contraceptive devices, as defined in the bill, including those available over-the-counter. The bill prohibits a health insurance carrier from imposing upon any person receiving contraceptive benefits pursuant to the provisions of the bill any copayment, coinsurance payment, or fee, except in certain circumstances.
STATUS
Vetoed
HB624 - English language learner students; ratios of instructional positions, At-Risk Program established.
Sam Rasoul, Shelly Anne Simonds, Elizabeth B. Bennett-Parker
Last updated 6 months ago
47 Co-Sponsors
Public school staffing and funding; National Teacher Certification Incentive Reward Program and Fund; At-Risk Program; English language learner students. Renames the National Teacher Certification Incentive Reward Program and Fund as the National Board Certification Incentive Reward Program and Fund, expands eligibility for incentive grant awards from such Fund pursuant to such Program from solely teachers who have obtained national certification from the National Board for Professional Teaching Standards to all public school staff who are candidates for initial national certification or maintenance of national certification to cover certain costs of obtaining or maintaining such certification and all public school staff who have successfully obtained or maintained such certification, and permits certain teachers to apply for additional incentive grants pursuant to such Program and Fund. The bill also establishes the At-Risk Program for the purpose of supporting programs and services for students who are educationally at risk, including prevention, intervention, or remediation activities required pursuant to relevant law, teacher recruitment programs and initiatives, programs for English language learners, the hiring of additional school counselors and other support staff, and other programs relating to increasing the success of disadvantaged students in completing a high school degree and providing opportunities to encourage further education and training. The bill also contains provisions relating to certain funding requirements for the At-Risk Program. Finally, the bill requires state funding to be provided pursuant to the general appropriation act to support ratios of instructional positions to English language learner students based on each such student's English proficiency level, as established in the general appropriation act.
STATUS
Vetoed
HB177 - Federal Early Intervention Program for Infants & Toddlers w/Disabilities; reimbursement rates.
Debra D. Gardner, Bonita Grace Anthony, Alex Q. Askew
Last updated 11 months ago
20 Co-Sponsors
Department of Medical Assistance Services; reimbursement rates for Early Intervention Program for Infants and Toddlers with Disabilities; work group; report. Directs the Department of Medical Assistance Services to convene a work group of relevant stakeholders to assess and make recommendations related to reimbursement rates for the federal Early Intervention Program for Infants and Toddlers with Disabilities. The bill requires the work group to report its recommendations to the Chairmen of the House Committee on Health, Welfare and Institutions and the Senate Committee on Education and Health by November 1, 2024.
STATUS
Introduced
HB509 - Students with disabilities; SCHEV to study process used to determine eligibility for accommodations.
Laura Jane Cohen, Irene Shin, Amy J. Laufer
Last updated 8 months ago
5 Co-Sponsors
State Council of Higher Education for Virginia; public institutions of higher education; policies for establishing eligibility for accommodations; report. Requires the State Council of Higher Education for Virginia, in consultation with representatives of public institutions of higher education, disability advocacy organizations, students enrolled at public institutions of higher education, higher education disability accommodation professionals, and a subject matter expert, to (i) study the processes by which each public institution of higher education in the Commonwealth determines the eligibility for accommodations of an admitted or enrolled student with a temporary or permanent disability, (ii) identify in such processes any potential barriers to establishing eligibility, and (iii) make recommendations on reducing any such barriers and on the development and establishment of a uniform accommodations eligibility determination in the Commonwealth.
STATUS
Passed
HB238 - Health insurance; coverage for colorectal cancer screening.
Delores L. McQuinn, Bonita Grace Anthony, Elizabeth B. Bennett-Parker
Last updated 8 months ago
24 Co-Sponsors
Health insurance; coverage for colorectal cancer screening. Requires health insurers to provide coverage for examinations and laboratory tests related to colorectal cancer screening in accordance with the most recently published recommendations established by the U.S. Preventive Services Task Force for colorectal cancer screening for which a rating of A or B is in effect with respect to the individual involved. The bill requires such coverage to include coverage of a follow-up colonoscopy after a positive noninvasive stool-based screening test or direct visualization screening test. The bill prohibits such coverage from being subject to any deductible, coinsurance, or any other cost-sharing requirements for services received from participating providers. The provisions of the bill apply to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans delivered, issued for delivery, or renewed in the Commonwealth on and after January 1, 2025. Health insurance; coverage for colorectal cancer screening. Requires health insurers to provide coverage for examinations and laboratory tests related to colorectal cancer screening in accordance with the most recently published recommendations established by the U.S. Preventive Services Task Force for colorectal cancer screening for which a rating of A or B is in effect with respect to the individual involved. The bill requires such coverage to include coverage of a follow-up colonoscopy after a positive noninvasive stool-based screening test or direct visualization screening test. The bill prohibits such coverage from being subject to any deductible, coinsurance, or any other cost-sharing requirements for services received from participating providers. The provisions of the bill apply to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans delivered, issued for delivery, or renewed in the Commonwealth on and after January 1, 2025.
STATUS
Passed
HB102 - Court-appointed counsel; raises the limitation of fees.
Atoosa R. Reaser, Jason S. Ballard, Patrick A. Hope
Last updated 8 months ago
33 Co-Sponsors
Compensation of court-appointed counsel. Raises the limitation of fees that court-appointed counsel can receive for representation on various offenses in district and circuit courts. The bill also limits the fees charged for the cost of court-appointed counsel or public defender representation to persons determined to be indigent to an amount no greater than the amount such person would have owed if such fees had been assessed on or before June 30, 2024. The bill has a delayed effective date of January 1, 2025.
STATUS
Passed
HB570 - Prescription Drug Affordability Board; established, drug cost affordability review, report.
Karrie K. Delaney, Nadarius E. Clark, Dan I. Helmer
Last updated 8 months ago
27 Co-Sponsors
Prescription Drug Affordability Board established; drug cost affordability review. Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with certain exceptions and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with identifying prescription, generic, and other drugs, as defined in the bill, that are offered for sale in the Commonwealth and, at the Board's discretion, conducting an affordability review of any prescription drug product. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. The bill provides that the Board shall establish no more than 12 upper payment limit amounts annually between January 1, 2025, and January 1, 2028. Prescription Drug Affordability Board established; drug cost affordability review. Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with certain exceptions and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with identifying prescription, generic, and other drugs, as defined in the bill, that are offered for sale in the Commonwealth and, at the Board's discretion, conducting an affordability review of any prescription drug product. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. The bill provides that the Board shall establish no more than 12 upper payment limit amounts annually between January 1, 2025, and January 1, 2028. The bill requires the Board to report its findings and recommendations to the General Assembly twice annually, beginning on July 1, 2025, and December 31, 2025. Provisions of the bill shall apply to state-sponsored and state-regulated health plans and health programs and obligate such policies to limit drug payment amounts and reimbursements to an upper payment limit amount set by the Board, if applicable, following an affordability review. The bill specifies that Medicare Part D plans shall not be bound by such decisions of the Board. The bill also requires the nonprofit organization contracted by the Department of Health to provide prescription drug price transparency to provide the Board access to certain data reported by manufacturers. The bill has a delayed effective date of January 1, 2025, and is identical to
STATUS
Vetoed
HJR27 - Coach Appreciation Week designating as week of October 6, 2024 and each succeeding year thereafter.
Marcia S. Price, Nadarius E. Clark, Joshua G. Cole
Last updated 9 months ago
16 Co-Sponsors
Coach Appreciation Week. Designates the week of October 6, in 2024 and in each succeeding year, as Coach Appreciation Week in Virginia.
STATUS
Passed
HB894 - Virginia Freedom of Information Act; electronic meetings.
Elizabeth B. Bennett-Parker, Adele Y. McClure, Joshua G. Cole
Last updated 9 months ago
12 Co-Sponsors
Virginia Freedom of Information Act; electronic meetings. Amends the number of all-virtual public meetings that public bodies, with certain exceptions, may convene in a calendar year to no more than two times per calendar year or 50 percent of the meetings held per calendar year rounded up to the next whole number, whichever is greater. Current law limits the number of all-virtual public meetings to no more than two times per calendar year or 25 percent of the meetings held per calendar year rounded up to the next whole number, whichever is greater. The bill also provides that with respect to all-virtual public meetings, when audio-visual technology is available, a member of a public body shall, for purposes of a quorum, be considered absent from any portion of the meeting during which visual communication with the member is voluntarily disconnected or otherwise fails or during which audio communication involuntarily fails.
STATUS
Passed
BIOGRAPHY
INCUMBENT
Representative from Virginia district HD-055
COMMITTEES
Virginia House
BIRTH
--
ABOUT
--
OFFICES HELD
Virginia House from Virginia
NEXT ELECTION
Amy hasn't been asked any questions.
Be the first to ask a questionVerifications Required
You must be a verified voter to do that.
Error
You must be a resident or registered voter in this state.